Literature DB >> 3820091

The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.

W F Ebling, W J Jusko.   

Abstract

Methods based on moment analysis are described which permit the calculation of the fundamental parameters of reversible drug/metabolite systems. These parameters include the four essential clearances of reversible and irreversible elimination, the central and steady-state distributional volumes, and the sojourn times or turnover rates of the metabolic pair. Additional parameters unique to interconversion systems are developed which describe the properties of metabolic entrapment ("recycled fraction"), conservation ("exposure enhancement"), and equilibrium resulting from reversible metabolism ("Percent parent drug at steady-state"). Parameters obtained by these methods are compared to those generated by conventional mammillary analysis. The influence of perturbation of essential parameters on the response of mammillary descriptors and the state of the interconversion system are simulated. The interconversion analysis is applied to disposition data for methylprednisolone and methylprednisone in the rabbit. Mammillary methods underestimate the metabolic clearance of these two steroids by 30%, while steroid turnover is underestimated by 100%. The steady-state volumes of distribution of the two steroids are overestimated by 10 and 61%. Additional literature data for disposition of several corticosteroids in various species and disease states are reanalyzed. Examination of cortisol/cortisone disposition in thyroid disorders reveals that mammillary methods detect the overall acceleration of steroid elimination in hyperthyroidism, but fail to reveal a 50% reduction in metabolite backconversion and decreased metabolic cycling. These moment analysis methods should facilitate characterization of the pharmacokinetics of the increasing array of reversible drug/metabolite systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3820091     DOI: 10.1007/bf01067965

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  37 in total

1.  Metabolism of 1-dehydrosteroids in man. II. Isolation of 20alpha- and 20beta-hydroxy metabolites.

Authors:  A VERMEULEN; E CASPE
Journal:  J Biol Chem       Date:  1959-09       Impact factor: 5.157

2.  The non-linear pharmacokinetics of prednisone and prednisolone. I. Theoretical.

Authors:  J J Ferry; J G Wagner
Journal:  Biopharm Drug Dispos       Date:  1986 Jan-Feb       Impact factor: 1.627

3.  The polymorphic acetylation of dapsone in man.

Authors:  R Gelber; J H Peters; G R Gordon; A J Glazko; L Levy
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

4.  Cortisol uptake, release and conversion into cortisone by the heart muscle in dogs.

Authors:  J Kolanowski; F Corcelle-Cerf; J Lammerant
Journal:  J Steroid Biochem       Date:  1981-08       Impact factor: 4.292

5.  A liner mode of reversible metabolism and its application to bioavailability assessment.

Authors:  S Hwang; K C Kwan; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

6.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Organ-specific ontogeneses of steroid hormone metabolizing enzyme activities in the rat.

Authors:  R Ghraf; U Vetter; J M Zandveld; H Schriefers
Journal:  Acta Endocrinol (Copenh)       Date:  1975-05

8.  Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.

Authors:  S J Szefler; W F Ebling; J W Georgitis; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Metabolic clearance rate and interconversion of androgens and the influence of the free androgen fraction.

Authors:  A Vermeulen; S Andó
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

10.  Dose-dependent protein binding and disposition of prednisolone in rabbits.

Authors:  M L Rocci; W J Jusko
Journal:  J Pharm Sci       Date:  1981-11       Impact factor: 3.534

View more
  21 in total

1.  SB-239063, a potent and selective inhibitor of p38 map kinase: preclinical pharmacokinetics and species-specific reversible isomerization.

Authors:  K W Ward; J W Proksch; L M Azzarano; K L Salyers; J E McSurdy-Freed; T M Molnar; M A Levy; B R Smith
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

Authors:  J P McGee; P N Shaw
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

3.  Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat.

Authors:  G M Meno-Tetang; Y Y Hon; S Van Wart; W J Jusko
Journal:  Drug Metabol Drug Interact       Date:  1999

4.  Reversible metabolism of vitamin K-vitamin K epoxide: modeling considerations and limitations.

Authors:  H O Hallak; P J Wedlund
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

5.  Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.

Authors:  M L Huang; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

6.  Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

7.  Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

Review 8.  Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?

Authors:  W H Chang
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

10.  Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patients.

Authors:  M W Jann; Y W Lam; W H Chang
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.